Table 2.

Exercise prescription program variables^a

Characteristic	Low-Dose (n=14)	High-Dose (n=12)	Δ Between Groups (LS Mean ± SE)	P
Volume (minutes of exercise per week)	141.5±9.92	247.2±10.71	105.7±14.60	<0.001
% adherence to prescribed exercise dose	92.8±2.44	89.0±2.64	−3.8±3.60	0.287
Frequency (days of exercise per week)	3.5±0.15	4.3±0.16	0.75±0.22	0.001
Fractionation (sessions of exercise per day)	1.1±0.07	1.4±0.07	0.31±0.10	0.001
Intensity (% of heart rate maximum)	71.6±1.16	69.6±1.27	−1.89±1.72	0.272
Time (minutes of exercise per day)	41.6±2.38	59.1±2.57	17.4±3.50	<0.001
Type (% of exercise sessions using treadmill)	72.3±12.9	81.3±15.5	8.0±18.71	0.669
Progression (weeks to full dose of exercise)b	4 [4–5]	8 [7–10]	4 [2–6]	0.007
% of exercise confirmed with heart rate monitor	97.3±0.81	96.2±0.87	−1.1±1.19	0.344
% with ≥80% adherence, n (%)	12 (86%)	9 (75%)	−10.6±15.2	0.488
MET hours per weekc	13.7±0.96	23.9±1.03	10.2±1.41	<0.001

^aData are least squares mean (LS Mean) ± standard error (SE) unless otherwise noted.

^bMedian [interquartile 25–75% range].

^cCalculated using treadmill speed and incline, and averaged across all exercise sessions.